Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | aryl hydrocarbon receptor | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | carnitine O palmitoyltransferase 2 | 0.0188 | 0.1509 | 0.3431 |
Echinococcus granulosus | tar DNA binding protein | 0.0193 | 0.1577 | 0.3585 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0259 | 0.2503 | 0.2503 |
Loa Loa (eye worm) | choline/Carnitine O-acyltransferase | 0.0188 | 0.1509 | 0.1509 |
Schistosoma mansoni | hypothetical protein | 0.0177 | 0.1345 | 0.7244 |
Brugia malayi | TAR-binding protein | 0.0193 | 0.1577 | 0.1577 |
Loa Loa (eye worm) | carnitine O-palmitoyltransferase I isoform | 0.0095 | 0.0191 | 0.0191 |
Loa Loa (eye worm) | hypothetical protein | 0.0095 | 0.0191 | 0.0191 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0177 | 0.1345 | 0.1345 |
Schistosoma mansoni | tar DNA-binding protein | 0.0193 | 0.1577 | 0.8494 |
Loa Loa (eye worm) | hypothetical protein | 0.0177 | 0.1345 | 0.1345 |
Brugia malayi | Choline O-acetyltransferase | 0.0095 | 0.0191 | 0.0191 |
Trypanosoma cruzi | carnitine O-palmitoyltransferase II, putative | 0.0188 | 0.1509 | 0.3132 |
Loa Loa (eye worm) | hypothetical protein | 0.0139 | 0.0808 | 0.0808 |
Brugia malayi | RNA binding protein | 0.0193 | 0.1577 | 0.1577 |
Loa Loa (eye worm) | TAR-binding protein | 0.0193 | 0.1577 | 0.1577 |
Echinococcus granulosus | choline O acetyltransferase | 0.0095 | 0.0191 | 0.0435 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0259 | 0.2503 | 0.2503 |
Trypanosoma brucei | carnitine O-palmitoyltransferase II, putative | 0.0188 | 0.1509 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0193 | 0.1577 | 0.1577 |
Loa Loa (eye worm) | hypothetical protein | 0.0158 | 0.1078 | 0.1078 |
Echinococcus multilocularis | choline O acetyltransferase | 0.0095 | 0.0191 | 0.0435 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0095 | 0.0191 | 0.0191 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.0213 | 0.1856 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0193 | 0.1577 | 0.3585 |
Schistosoma mansoni | choline o-acyltransferase | 0.0095 | 0.0191 | 0.103 |
Echinococcus multilocularis | aryl hydrocarbon receptor | 0.0159 | 0.1087 | 0.2471 |
Leishmania major | choline/Carnitine o-acyltransferase-like protein | 0.0393 | 0.4399 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0193 | 0.1577 | 0.1577 |
Schistosoma mansoni | tar DNA-binding protein | 0.0193 | 0.1577 | 0.8494 |
Echinococcus granulosus | carnitine O palmitoyltransferase 2 | 0.0188 | 0.1509 | 0.3431 |
Schistosoma mansoni | choline o-acyltransferase | 0.0095 | 0.0191 | 0.103 |
Brugia malayi | Choline O-acetyltransferase | 0.0095 | 0.0191 | 0.0191 |
Echinococcus granulosus | aryl hydrocarbon receptor | 0.0159 | 0.1087 | 0.2471 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0193 | 0.1577 | 0.1577 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0393 | 0.4399 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.014 | 0.0817 | 0.0817 |
Onchocerca volvulus | 0.0158 | 0.1078 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0788 | 1 | 1 |
Leishmania major | carnitine palmitoyltransferase-like protein | 0.0188 | 0.1509 | 0.3132 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0393 | 0.4399 | 1 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 1, liver | 0.0393 | 0.4399 | 1 |
Echinococcus granulosus | carnitine O palmitoyltransferase 1 liver | 0.0393 | 0.4399 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0259 | 0.2503 | 0.2503 |
Brugia malayi | aryl hydrocarbon receptor AHR-1 | 0.0139 | 0.0808 | 0.0808 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0188 | 0.1509 | 0.1509 |
Schistosoma mansoni | tar DNA-binding protein | 0.0193 | 0.1577 | 0.8494 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0259 | 0.2503 | 0.2503 |
Schistosoma mansoni | tar DNA-binding protein | 0.0193 | 0.1577 | 0.8494 |
Loa Loa (eye worm) | choline O-acetyltransferase | 0.0095 | 0.0191 | 0.0191 |
Schistosoma mansoni | tar DNA-binding protein | 0.0193 | 0.1577 | 0.8494 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.7306 uM | PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 4.4668 uM | PubChem BioAssay. qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.2289 uM | PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of farnesoid X receptor signaling. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 79.4328 um | PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.